Anshu M. Roy

542 total citations
11 papers, 405 citations indexed

About

Anshu M. Roy is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anshu M. Roy has authored 11 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Genetics. Recurrent topics in Anshu M. Roy's work include Angiogenesis and VEGF in Cancer (4 papers), Cell death mechanisms and regulation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anshu M. Roy is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Cell death mechanisms and regulation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anshu M. Roy collaborates with scholars based in United States and India. Anshu M. Roy's co-authors include Santosh K. Katiyar, Manjeshwar Shrinath Baliga, Craig A. Elmets, Rongbao Li, Zhican Qu, Yulia Maxuitenko, William E. Grizzle, Delicia Carey, Louise Westbrook and Florian Kern and has published in prestigious journals such as Cancer Research, European Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Anshu M. Roy

11 papers receiving 393 citations

Peers

Anshu M. Roy

PFM

ONCOL

BIOCH

PHARM

Hui-Ying Huang Taiwan

Myung Gu Jung South Korea

Vijay S. Thakur United States

Yao-Ping Lu United States

Woo-Kwang Jeon South Korea

Sudhandiran Ganapasam India

Zhou Yingfeng China

Kalimuthu Senthilkumar India

Melissa A. Babcook United States

Todd Schuster United States

Hui-Ying Huang Taiwan

Anshu M. Roy

259 ×1.3

46 ×0.6

PFM

51 ×0.7

ONCOL

35 ×0.5

BIOCH

37 ×0.7

PHARM

Citations per year, relative to Anshu M. Roy Anshu M. Roy (= 1×) peers Hui-Ying Huang

Countries citing papers authored by Anshu M. Roy

Since Specialization

Citations

This map shows the geographic impact of Anshu M. Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anshu M. Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anshu M. Roy more than expected).

Fields of papers citing papers by Anshu M. Roy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anshu M. Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anshu M. Roy. The network helps show where Anshu M. Roy may publish in the future.

Co-authorship network of co-authors of Anshu M. Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Anshu M. Roy. A scholar is included among the top collaborators of Anshu M. Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anshu M. Roy. Anshu M. Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Rajagopal, Sridharan, D. Prabhu, Praveen Rajendran, et al.. (2015). Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. European Journal of Medicinal Chemistry. 108. 274–286. 7 indexed citations

Zamani, Ali, Anshu M. Roy, Ling Zhai, et al.. (2012). Abstract 2333: Serotonin: A known neurotransmitter functions as an angiokine to support cancer progression. Cancer Research. 72(8_Supplement). 2333–2333. 1 indexed citations

Zamani, Ali, Ling Zhai, Anshu M. Roy, et al.. (2011). Abstract 5154: Serotonin signaling as a novel target of tumor angiogenesis. Cancer Research. 71(8_Supplement). 5154–5154. 3 indexed citations

Roy, Anshu M., Ali Zamani, Subramaniam Ananthan, & Zhican Qu. (2009). Abstract #4035: Serotonin: A neurotransmitter as well as a potent angiokine. Cancer Research. 69. 4035–4035. 1 indexed citations

Qu, Zhican, Anshu M. Roy, Louise Westbrook, et al.. (2008). Vascular Endothelial Growth Factor Reduces Tamoxifen Efficacy and Promotes Metastatic Colonization and Desmoplasia in Breast Tumors. Cancer Research. 68(15). 6232–6240. 33 indexed citations

Roy, Anshu M., Rongbao Li, & Zhican Qu. (2006). Antiangiogenic activity of clofarabine. Cancer Research. 66. 55–56. 3 indexed citations

Roy, Anshu M., Kamal N. Tiwari, William B. Parker, et al.. (2006). Antiangiogenic activity of 4′-thio-β-d-arabinofuranosylcytosine. Molecular Cancer Therapeutics. 5(9). 2218–2224. 12 indexed citations

Katiyar, Santosh K., Anshu M. Roy, & Craig A. Elmets. (2005). Green tea polyphenols inhibit photocarcinogenesis in mice through induction of IL-12, and IL-12-mediated immune responses in skin tumors. Cancer Research. 65. 1017–1017. 1 indexed citations

Roy, Anshu M., Manjeshwar Shrinath Baliga, Craig A. Elmets, & Santosh K. Katiyar. (2005). Grape Seed Proanthocyanidins Induce Apoptosis through p53, Bax, and Caspase 3 Pathways. Neoplasia. 7(1). 24–36. 85 indexed citations

10.

Roy, Anshu M., Manjeshwar Shrinath Baliga, & Santosh K. Katiyar. (2005). Epigallocatechin-3-gallate induces apoptosis in estrogen receptor–negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Molecular Cancer Therapeutics. 4(1). 81–90. 138 indexed citations

11.

Katiyar, Santosh K., Anshu M. Roy, & Manjeshwar Shrinath Baliga. (2005). Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Molecular Cancer Therapeutics. 4(2). 207–216. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact